Article
Ribavirin-induced mutagenesis across the complete open reading frame of hepatitis C virus genotypes 1a and 3a.
The Journal of general virology - 1 Aug 2018
Mejer Niels, Fahnøe Ulrik, Galli Andrea, Ramirez Santseharay, Benfield Thomas, Bukh Jens
Abstract excerpt
Ribavirin (RBV) has been used for the last 20 years to treat patients with chronic hepatitis C virus (HCV) infection. This pluripotent drug is believed to induce mutagenesis in HCV RNA. However, for cell-cultured HCV (HCVcc) this phenomenon has only been investigated in genotype 2a recombinants. Here we studied the mutations that developed in HCVcc of genotypes 1a and 3a treated with RBV or ribavirin triphosphate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
